# INTERVIEW: Optibiotix Health Plc High Commercial Interest Turning To Fruition

- Link: https://www.directorstalkinterviews.com/interview-optibiotix-health-plc-high-commercial-interest-turning-fruition/412733582
- Published: 2017-08-14T10:11:56+01:00
- Author: Giles Arbor

**Optibiotix Health Plc** (LON:OPTI) CEO Stephen O’Hara talks to DirectorsTalk about
the recent share price movement. Stephen also talks about the potential for 39 RNS’s
that could be announced over the coming months as opportunities turn to fruition.

 

OptiBiotix Health Plc was formed in March 2012 to develop compounds which modify
the human microbiome – the collective genome of the microbes in the body – to prevent
and manage human disease. The aim of the company is to discover and develop microbial
strains, compounds and formulations, which modulate the human microbiome and can
be used as food ingredients and supplements or active compounds for the prevention
and management of human metabolic diseases, examples of which include obesity, cholesterol
and lipid distribution and diabetes.

OptiBiotix has established a pipeline of microbiome modulators that can impact on
lipid and cholesterol management, energy harvest and appetite suppression. The development
pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies
designed to identify metabolic pathways and compounds that impact on human physiology
and bring potential health benefits. These platforms are applicable across a wider
range of other human diseases.

 

Share on: